Modernising autism spectrum disorder model engineering and treatment

Area of Science:

• Neuroscience
• Genetics
• Biotechnology

Background:

• Autism spectrum disorder (ASD) is a complex neurodevelopmental condition characterized by social interaction deficits, communication challenges, and repetitive behaviors.
• The precise genetic underpinnings of ASD are not fully understood, and a lack of adequate models hinders research.
• Current therapeutic strategies for ASD are limited, emphasizing the need for novel approaches.

Purpose of the Study:

• To review and analyze the application of the CRISPR-Cas9 system in autism spectrum disorder research.
• To explore how CRISPR-Cas9 facilitates the creation of accurate ASD models.
• To discuss the potential of CRISPR-Cas9 in addressing ASD complexities and therapeutic avenues.

Main Methods:

• Utilizing the CRISPR-Cas9 system for precise genome editing in various model systems.
• Developing in vitro cell lines, 3D organoid models, and in vivo animal models to mimic ASD pathology.
• Analyzing existing literature on CRISPR-Cas9 applications in ASD research.

Main Results:

• CRISPR-Cas9 enables the precise genetic modification required to establish robust ASD models.
• These models, including cell lines, organoids, and animal models, effectively recapitulate key features of ASD.
• The technology shows promise for investigating ASD pathogenesis and exploring gene-editing-based therapeutic strategies.

Conclusions:

• The CRISPR-Cas9 system is a transformative tool for advancing autism spectrum disorder research.
• It significantly improves the ability to model ASD, facilitating a deeper understanding of its complex mechanisms.
• CRISPR-Cas9 holds potential for developing novel therapeutic interventions for individuals with ASD.